Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2NG/ML strongly predict risk of amenorrhea in women with breast cancer Meeting Abstract


Authors: Oktay, K. H.; Turan, V.; Bedoschi, G.; Goldfarb, S.; Bang, H.
Abstract Title: Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2NG/ML strongly predict risk of amenorrhea in women with breast cancer
Meeting Title: 78th Scientific Congress of the American Society for Reproductive Medicine (ASRM)
Journal Title: Fertility and Sterility
Volume: 118
Issue: 4 Suppl.
Meeting Dates: 2022 Oct 22-26
Meeting Location: Anaheim, California
ISSN: 0015-0282
Publisher: Elsevier Science, Inc.  
Date Published: 2022-10-01
Start Page: e231
Language: English
DOI: 10.1016/j.fertnstert.2022.08.652
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting abstract: P-291 -- In E-Poster Abstract Session T8 -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Shari Goldfarb
    149 Goldfarb